Evidence map›Paper›PMID 40528839›Full record

ReviewMaterials today. Bio2025

Advancements in two-dimensional nanomaterials for regenerative medicine in skeletal muscle repair.

Hongyu Bai, Lu Liu, Zhiwen Luo, Renwen Wan, Jiwu Chen

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongyu BaiDepartment of Sports Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.
Lu LiuDepartment of Sports Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.
Zhiwen LuoDepartment of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Renwen WanDepartment of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Jiwu ChenDepartment of Sports Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle, the largest organ in the human body, plays vital roles in movement, heat generation, and internal organ protection. While healthy muscle can regenerate effectively, its regenerative capacity declines in conditions like congenital muscular dystrophy, severe trauma, or aging. Two-dimensional (2D) nanomaterials, with unique physicochemical properties such as high surface area, excellent biocompatibility, and tunable mechanical and electrical properties, have shown great promise in different forms of muscle injury, particularly in volumetric muscle loss (VML). Recent studies highlight their diverse applications in muscle regeneration, acting as cell recruitment platforms, drug delivery carriers, structural scaffolds, and anti-inflammatory agents. Additionally, their biological effects and intelligent responsiveness are emerging as key features. Despite these advances, safety concerns regarding toxicity and biodegradability remain a challenge for clinical application. To unlock the full potential of 2D materials, further research is needed, especially through interdisciplinary collaboration to better understand their biological effects. By addressing safety issues and harnessing their multifunctional and intelligent characteristics, 2D nanomaterials can offer a more effective and sustainable approach to skeletal muscle repair, paving the way for next-generation therapies in regenerative medicine.

Indexed as

Regenerative medicineSkeletal muscle repairTwo-dimensional nanomaterials

Identifiers

PMID40528839
PMCPMC12173613

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.